(PharmaNewsWire.Com, March 23, 2018 ) Global Acne Medication Market was worth USD xx billion in 2017 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2022. Acne is a skin disease which is characterized by pimples, oily skin and blackheads. It can be caused due to dead skin cells, clogged hair follicles and oil from the skin. It generally affects the region with a considerably higher number of sweat glands like upper part of chest, back and face.
Unhealthy urban lifestyle and growing number of cases of acne are the major factors driving the market growth. As people are becoming conscious about their looks, the market is expected to propel during the forecast period. However, side effects associated with the use of acne medication and alternative treatments available in the market are hampering the market growth
The market for Acne Medication is broadly categorized into type, route of administration and drug class. By type the market is divided into OTC and prescription drugs. By route of administration the market is segmented into Oral and topical. By drug class the market is classified into Antibiotics, anti-inflammatory drugs, anti microbial, combination drugs, hormonal agents, oral retinoids and topical retinoids. Anti-inflammatory segment holds a major share of the market revenue. On the basis of geography, the market is analysed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Acne Medication market was dominated by Europe closely followed by North America. Asia Pacific is expected to grow at a high CAGR.
Market Segmentation Type • Introduction • OTC drugs • Prescription drugs • Y-o-Y Growth Analysis, By type • Market Attractiveness Analysis, By type • Market Share Analysis, By type Route of administration • Introduction • Topical • Oral • Y-o-Y Growth Analysis, By route of administration • Market Attractiveness Analysis, By route of administration • Market Share Analysis, By route of administration Drug class • Introduction • Antibiotics • Anti-inflammatory drugs • Anti-microbials • Combination drugs • Hormonal agents • Oral retinoids • Topical retinoids • Y-o-Y Growth Analysis, By drug class • Market Attractiveness Analysis, By drug class • Market Share Analysis, By drug class Some of the major companies dominating the market, by their products and services include Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd.,
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: